The debate over the use of race-day medication, in particular the use of Lasix in North America has been heating up over the past year or so being fueled by the Jockey Club and WHOA on one side and the Horsemens/Trainer/Veterinary groups on the other. Lines have been drawn on the argument and battle cries/talking points well rehearsed with most of it rather emotive and little being based on the science of EIPH at all. The scientific community has published pretty extensively

For as long as I can remember – and admittedly it is not as long as some – there has been a continual question over the soundness of the Thoroughbred racehorse. While, in recent history, the death of Eight Belles at the Kentucky Derby caused the North American industry to, at least for a moment, to confront the issue, it is one that in reality has been present, if not always front and center, for a far longer period of time. In recent years there has been a significant push f

Abstracts have just been released for the upcoming Equine Science Society Symposium to be held in New Mexico at the end of May. Among the abstracts is a very interesting paper on EIPH completed by Dr Joe Pagan and colleagues. The abstract reads: Furosemide reduces the energetic cost of exercise in Thoroughbreds independent of its effect on EIPH J.D. Pagan, B.M. Waldridge, C. Whitehouse, L. Dalglish, S. Fuchs, and M. Goff Kentucky Equine Research, Inc., Versailles, KY 40383 Si